The mission of the Cancer Biology Laboratory is to develop smart cancer therapeutics with increased potency and decreased side effects.

We use phage display screens to identify homing peptides that bind to specific targets in the vasculature. Corresponding synthetic peptides are explored for targeting drugs, biologicals, and nanoparticles into tumors to increase their therapeutic index. Our scope includes understanding the molecular interactions involved to drive specificity and activity, focusing on Tumor Penetrating Peptides (TPP) that trigger bulk extravascular transport in the tumor tissue.

News

  • We look for talented M.Sc. and PhD candidates to join our lab in fall 2019 We look for talented M.Sc. and PhD candidates to join our lab in fall 2019

    Written on Friday, 18 January 2019 11:48

    We look for talented M.Sc. and PhD candidates (molecular medicine, cancer biology, drug delivery, nanomedicine) to join our lab in fall 2019. Apply now: This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Dr. Teesalu has given a series of invited talks on international conferences in Europe and in the US Dr. Teesalu has given a series of invited talks on international conferences in Europe and in the US

    Written on Tuesday, 16 October 2018 10:31

    Dr. Teesalu has given a series of invited talks on international conferences in Europe and in the US: The 4th Brain Tumors Conference 2018: From…
  • New nanoparticles for detection of small breast tumors with PET imaging reported in Oncotarget New nanoparticles for detection of small breast tumors with PET imaging reported in Oncotarget

    Written on Thursday, 24 May 2018 12:52

    We have designed new nanoparticles that detect small breast tumors using the clinically used medical imaging modality Positron Emission Tomography (PET). The particles are polymeric…

EMBO

ERC

wellcome trust

norwaygrants logo new

  

 

Recent publications

Images